Selecta Biosciences, Inc.
Selecta Biosciences, Inc.（SELB）股价预测与分析师目标价
华尔街共识、12 个月目标价、模型推演与 EPS/营收预期 — 来自分析师数据与历史行情。
selb · 股价预测 · 11 位分析师（近3月）· FMP · 更新于 2026年6月9日
分析师评级与共识
基于过去 3 个月内 11 位华尔街分析师
Buy
11 位分析师
共识
评级分布
12 个月目标价
High
$0.00
Consensus
$0.00
+0.0% upside
Low
$0.00
Median: $0 · Last Close: $0.67
短期股价预测
Bear算法生成 · 每日更新
| Date | Predicted Price | Change |
|---|---|---|
| 2026-06-10 | $0.63 | ↓ 5.00% |
1-day model range: $0.62–$0.65. Peak: $0.65 (-5.00%).
长期股价预测
年度股价预测 · 2027 / 2028 / 2029 / 2030 / 2031
| Year | Avg Price | Change |
|---|---|---|
| 2027 | $0 | -50.0% |
| 2028 | $0 | -62.5% |
| 2029 | $0 | -67.2% |
| 2030 | $0 | -69.2% |
| 2031 | — | -70.2% |
基于技术分析的股价预测
14 项技术面信号（SMA×6 + EMA×6 + RSI + MACD）· EEAT 方法论透明
Market Sentiment
BEARISH
Based on 14 technical indicators
Refreshes daily from EOD close
Moving Averages · SELB · Jun 9, 2026
最新分析师评级与调整
| Date | Brokerage | Action | Rating |
|---|---|---|---|
| 2023-08-18 | Needham | Maintains | Buy→Buy |
| 2023-08-18 | Mizuho | Maintains | Buy→Buy |
| 2023-08-18 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2023-08-18 | SVB Leerink | Downgrade ↓ | Outperform→Market Perform |
| 2023-08-17 | SVB Leerink | Downgrade ↓ | Outperform→Market Perform |
| 2023-08-17 | Mizuho | Maintains | Buy→Buy |
| 2023-08-17 | Needham | Maintains | Buy→Buy |
| 2023-08-17 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2023-05-08 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2023-05-05 | Needham | Maintains | Buy→Buy |
Wall Street analysts have recently issued updated ratings on Selecta Biosciences, Inc. (SELB) stock. Of the recent 54 rating actions, 4 were upgrades and 6 were downgrades. 11 analysts currently cover SELB.
分析师推荐趋势
SELB analyst recommendation trends show increasing buy-side sentiment over the past 6 months. Buy rating actions changed from 5 to 6 per month.
财务预测：EPS 与营收一致预期
Revenue This Year
$49M
↓ 20.9% YoY
Revenue Next Year
$29M
↓ 40.4% YoY
EPS This Year
$-0.23
EPS Next Year
$-0.35
↑ 53.0% YoY
EPS ForecastReported vs Estimated
Analysts forecast SELB EPS of $-0.23 for the current fiscal year, based on estimates from 3 analysts. The SELB revenue forecast is $49M for the current year. These are analyst consensus estimates via FMP / S&P Global.
关于预测与目标价
SELB 股价预测由两类独立数据源支撑：来自 11 位华尔街分析师（S&P Global / FMP）的共识评级，以及基于历史日终价计算的技术分析。SELB 的共识目标价为 $0.00（+0.0% 上行空间），分析师共识为 Buy。
SELB 的短期预测（明日）为 $0.63（-5.00%）。 SELB 对 2027 年的股价预测均值为 $0。 SELB 对 2030 年的预测区间为 $0–$0。
Selecta Biosciences, Inc. 在 NASDAQ 上市，代码 SELB。SELB 在 2027 年的整体展望偏积极，在覆盖分析师中约 91% 对应 Buy 共识。
常见问题
SELB 预测 · 8 个问题根据 11 位华尔街分析师，SELB 的 12 个月平均目标价为 $0.00，最高 $0.00、最低 $0.00。若有图表，中位目标价可在上方查看。相对当前价 $0.67，隐含约 +0.0% 的上行空间。
· Analyst data: Financial Modeling Prep (FMP) · S&P Global Market Intelligence · Technical analysis: FMP /historical-price-eod/light · Updated: Hourly (analyst) · Daily (technical)
⚠ This information is provided for informational purposes only and does not constitute investment advice. Short-term and long-term price predictions are algorithmically generated and carry significant uncertainty. Past performance does not guarantee future results. Always conduct your own due diligence before making investment decisions.